Locally advanced noninflammatory breast cancer

Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges.

ESMO open·2025

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2024

IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer.

NPJ breast cancer·2023

Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer.

ESMO open·2022

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study.

Breast cancer research and treatment·2019

Incidence, Management, and Clinical Outcomes of Cardiovascular Adverse Events in Patients Receiving ALK Inhibitors for Advanced Non-Small Cell Lung Cancer: A Real-World Single-Center Analysis.

Cancer investigation·2026

Optimizing Cancer Drug Treatments Using Big Data Integration of Genomic and Clinical Data for Personalized Medicine.

Cancer investigation·2026

The Effect of Melatonin on Sleep Quality, Anxiety, and Depression in Patients with Primary Breast Cancer Undergoing Adjuvant Chemotherapy Type: A Randomized, Double-Blind, Placebo-Controlled Trial.

Cancer investigation·2026

A Comparative Analysis of TIRADS and ATA Classification Systems in Determining the Malignancy of Thyroid Nodules.

Cancer investigation·2026

Racial Differences in Outcomes Among Patients with Multiple Myeloma Treated at a Myeloma Center of Excellence: A Retrospective Cohort Study.

Cancer investigation·2026

Redefining Oligometastatic Pancreatic Ductal Adenocarcinoma: Biology, Diagnosis, and Precision Multimodal Therapy.

Cancer investigation·2026

Acute adrenal crisis after orchiectomy for testicular adrenal rest tumors in untreated congenital adrenal hyperplasia.

JCEM case reports·2026

The great masquerader: a case report of intrathyroidal hypofunctional normocalcemic parathyroid carcinoma mimicking a benign thyroid nodule.

Gland surgery·2026

Correction: Gonzalez-Sanchez et al. Epithelial to Mesenchymal Transition Transcriptional Regulator ZEB1 in Liver Cancer: Oncogenic Roles and Therapeutic Potential. Int. J. Mol. Sci. 2025, 26, 11135.

International journal of molecular sciences·2026

Redox Homeostasis, Metabolic Pathways and Plasticity in Uveal Melanoma Compared to Other Cancers.

Cancers·2026

Request for Clarification on Data Presentation in Table 2, Figures 3 and 4 of Onuki et al. (Cancer Science 2020).

Cancer science·2026

Collision tumor of medullary and papillary thyroid carcinoma with coexisting follicular adenoma: a unique triple pathology case report and review of literature.

Annals of medicine and surgery (2012)·2026

Related Experiment Videos

Locally advanced noninflammatory breast cancer

Related Concept Videos

Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges.

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).

IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.

Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer.

Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer.

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study.

Incidence, Management, and Clinical Outcomes of Cardiovascular Adverse Events in Patients Receiving ALK Inhibitors for Advanced Non-Small Cell Lung Cancer: A Real-World Single-Center Analysis.

Optimizing Cancer Drug Treatments Using Big Data Integration of Genomic and Clinical Data for Personalized Medicine.

The Effect of Melatonin on Sleep Quality, Anxiety, and Depression in Patients with Primary Breast Cancer Undergoing Adjuvant Chemotherapy Type: A Randomized, Double-Blind, Placebo-Controlled Trial.

A Comparative Analysis of TIRADS and ATA Classification Systems in Determining the Malignancy of Thyroid Nodules.

Racial Differences in Outcomes Among Patients with Multiple Myeloma Treated at a Myeloma Center of Excellence: A Retrospective Cohort Study.

Redefining Oligometastatic Pancreatic Ductal Adenocarcinoma: Biology, Diagnosis, and Precision Multimodal Therapy.

Acute adrenal crisis after orchiectomy for testicular adrenal rest tumors in untreated congenital adrenal hyperplasia.

The great masquerader: a case report of intrathyroidal hypofunctional normocalcemic parathyroid carcinoma mimicking a benign thyroid nodule.

Correction: Gonzalez-Sanchez et al. Epithelial to Mesenchymal Transition Transcriptional Regulator ZEB1 in Liver Cancer: Oncogenic Roles and Therapeutic Potential. Int. J. Mol. Sci. 2025, 26, 11135.

Redox Homeostasis, Metabolic Pathways and Plasticity in Uveal Melanoma Compared to Other Cancers.

Request for Clarification on Data Presentation in Table 2, Figures 3 and 4 of Onuki et al. (Cancer Science 2020).

Collision tumor of medullary and papillary thyroid carcinoma with coexisting follicular adenoma: a unique triple pathology case report and review of literature.

Related Experiment Videos

Locally advanced noninflammatory breast cancer

Related Concept Videos

Related Articles